Oncology/Hematology

Other Cancers

Latest AI and machine learning research in other cancers for healthcare professionals.

8,952 articles
Stay Ahead - Weekly Other Cancers research updates
Subscribe
Browse Categories
Showing 2101-2120 of 8,952 articles

Automated Gross Tumor Volume (GTV) Contouring in High-Grade Gliomas Using a Deep Learning Approach.

RATIONALE AND OBJECTIVES: Accurate contouring of the Gross Tumor Volume (GTV) in High-Grade Gliomas (HGGs) is a cornerstone of effective Radiation Therapy (RT) planning, as it influences tumor control and spares normal tissue, thereby directly impacting treatment precision. However, the standard manual approach to GTV contouring requires considerable time and is prone to inter-observer variability...

Jan 15 2026 41545259

Lymph Node Metastasis-Associated Spatiotemporal Mapping of the TFF3-Linked Niche in Breast Cancer: Integrating Radiogenomic Signatures with Immune-Ecosystem Remodeling.

Primary breast cancer (PBC) with axillary lymph node metastasis (ALNM+) is associated with distinct clinical outcomes, including reduced survival (The Cancer Genome Atlas/Foshan cohorts, P < 0.05) and an attenuated response to anti-programmed cell death protein 1 antibody/anti-programmed death-ligand 1 antibody (anti-PD-1/anti-PD-L1) therapy. Through ALNM-stratified single-cell RNA sequencing prof...

Jan 15 2026 41551914
B-cell-directed Immunotherapy for Solid Tumors.

B-cell-directed immunotherapy holds great promise for treating solid tumors, where barriers such as desmoplastic stroma and low immunogenicity have li...

Jan 14 2026 41903994
Integrating CAR-T therapy with PD-1/PD-L1 blockade: Mechanisms, synergy, and optimized strategies in NSCLC.

Non-small cell lung cancer (NSCLC) presents persistent challenges in immunotherapy, as the clinical benefit of programmed cell death protein 1 (PD-1) ...

Jan 14 2026 41675056
Application of copper based single-atom nanozymes in wound healing and tumor treatment.

Single-atom nanozymes (SANs) with transition metals as their core are nanomaterials characterized by atomically dispersed active sites and intrinsic e...

Jan 14 2026 41369074
Comprehensive review on immunotherapy for hepatocellular carcinoma: Current status and future perspectives.

Hepatocellular carcinoma (HCC), the most common form of primary liver cancer, remains a major global health concern due to its high incidence and mort...

Jan 14 2026 41532498
Concluding remarks: Achievements, challenges, and trajectories for high-entropy alloy nanoparticles.

The field of high-entropy alloy nanoparticles (HEA-NPs) had to move and indeed has moved beyond the early enthusiasm of simply "mixing five or more el...

Jan 14 2026 41532566
AI-powered hierarchical classification of ampullary neoplasms: a deep learning approach using white-light and narrow-band imaging.

BACKGROUND: Endoscopic diagnosis of Ampulla of Vater (AoV) lesions remains challenging owing to complex morphology and limited representative images, ...

Jan 14 2026 41532990
Effectiveness of Machine Learning in Detecting Vessels Encapsulating Tumor Clusters in Hepatocellular Carcinoma: Systematic Review and Meta-Analysis.

BACKGROUND: Vessels encapsulating tumor clusters (VETC) are significantly associated with poor prognosis in hepatocellular carcinoma (HCC). However, i...

Jan 14 2026 41534080
Nerves Stimulates Crosstalk between Gastric Cancer and Group 3 Innate Lymphoid Cells to Enhance Immunosuppression.

The immunosuppressive tumor microenvironment (TME) enables cancer cells to evade clinical immunotherapies. Neural networks are vital components of the...

Jan 14 2026 41534088
Multi-center multi-omics integration predicts individualized prognosis in medullary thyroid carcinoma.

Medullary thyroid carcinoma (MTC) is a rare, aggressive neuroendocrine tumor with limited treatment options and frequent recurrence. Comprehensive rec...

Jan 14 2026 41535264
Identification and validation of a refined CAF-Associated diagnostic signature in breast cancer.

Breast cancer remains a major global health challenge with high incidence and mortality rates among women. Recent studies have highlighted the critica...

Jan 14 2026 41535351
Effect of Helicobacter pylori infection on deep learning-assisted detection of gastric neoplastic lesions under white light endoscopy.

BACKGROUND: Artificial intelligence (AI)-assisted endoscopy facilitates upper gastrointestinal lesion detection. Whether Helicobacter pylori (H. pylor...

Jan 14 2026 41535450
A multi-modal approach for decision making in bladder cancer.

Bladder cancer remains a major global health challenge, characterized by diagnostic uncertainty, substantial treatment costs and high recurrence rates...

Jan 14 2026 41535603
Integrating single-cell and bulk transcriptomes with machine learning reveals a CAF signature for immunotherapy response in dMMR endometrial cancer.

BACKGROUND: Cancer-associated fibroblasts (CAFs) are key players in the tumor microenvironment (TME), but their roles in prognosis and immunotherapy r...

Jan 14 2026 41535649
Gut dysbiosis in oncology: a risk factor for immunoresistance.

The gut microbiome is recognized as a determinant of response to immune checkpoint inhibitor (ICI) therapies in cancer. However, the clinical translat...

Jan 14 2026 41535719
Diagnostic performance of convolutional neural network-based AI in detecting oral squamous cell carcinoma: a meta-analysis.

PURPOSE: To evaluate the diagnostic accuracy of artificial intelligence (AI) based on convolutional neural network (CNN) in diagnosing oral squamous c...

Jan 14 2026 41535840
A combinatorial transcription factor screening platform for immune cell reprogramming.

Direct reprogramming of immune cells holds promise for immunotherapy but is constrained by limited knowledge of transcription factor (TF) networks. He...

Jan 14 2026 41539305
Cutting-Edge AI Technologies in Skin Cancer Applications.

The rapid development of multimodal large language models (LLMs) such as GPT and Med-PaLM is reshaping medical practice. Skin cancer, one of the most ...

Jan 14 2026 41544780
Next-generation lung-cancer-on-a-chip: toward personalized therapy, AI, and CRISPR-driven models.

Lung-cancer-on-a-chip (LCOC) technologies have advanced rapidly, yet most models evaluate mechanical strain, patient-derived tumors, multi-organ inter...

Jan 14 2026 41544897
Browse Categories